STARS experts redefine stuttering as a brain-based neuropsychiatric disorder, urging interdisciplinary care and warning dopamine-boosting ADHD or antidepressant meds may worsen symptoms.
Shahriar SheikhBahaei, PhD
Advertisement
Dr Shahriar SheikhBahaei is an Empire Innovation Assistant Professor of Neurobiology at the State University of New York, Stony Brook.
Articles by Shahriar SheikhBahaei, PhD
Shahriar SheikhBahaei, PhD, discusses how animal models may lead to better treatments.
Shahriar SheikhBahaei, PhD, shares insights into the neurobiology of stuttering at STARS conference.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
FAQ: What Clinicians Need to Know About Postpartum Psychosis
2
Xanomeline/Trospium in Treatment-Refractory Bipolar I Disorder With Psychosis: A Case Report of Rapid Agitation Control and Functional Improvement
3
FDA Approves Oveporexton for Narcolepsy Type 1, First Drug to Treat Full Range of NT1 Symptoms
4
Psychiatry Mid-Year Market Update 2026: Persistent Demand, Widening Valuation Gap, and Workforce/Regulatory Realities
5